ID

42909

Description

Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Keywords

Versions (2)
  1. 8/26/17 8/26/17 -
  2. 9/17/21 9/17/21 -
Copyright Holder

gsk

Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

TIME AND EVENTS TABLE Ropinirole Case Report Form GSK RRL100013

German English

TIME AND EVENTS TABLE Ropinirole Case Report Form GSK

1 forms  
TIME AND EVENTS TABLE
Description

TIME AND EVENTS TABLE

Assessments
Description

Assessments

Data type

integer

Alias
UMLS CUI [1]
C0220825
IRLSSG diagnostic criteria
Description

IRLSSG diagnostic criteria

Data type

integer

Alias
UMLS CUI [1,1]
C0035258
UMLS CUI [1,2]
C2348561
Inclusion/exclusion criteria
Description

Inclusion/exclusion criteria

Data type

integer

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Subject demography
Description

Subject demography

Data type

integer

Alias
UMLS CUI [1]
C0011298
RLS history
Description

RLS history

Data type

integer

Alias
UMLS CUI [1]
C0035258
Orthostatic blood pressure and heart rate
Description

Orthostatic blood pressure and heart rate

Data type

integer

Alias
UMLS CUI [1]
C1095971
Weight
Description

Weight

Data type

integer

Alias
UMLS CUI [1]
C0220825
Height
Description

Height

Data type

integer

Alias
UMLS CUI [1]
C0005890
ECG
Description

ECG

Data type

integer

Alias
UMLS CUI [1]
C0220825
Medical/surgical history
Description

Medical/surgical history

Data type

integer

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0455610
Physical examination
Description

Physical examination

Data type

integer

Alias
UMLS CUI [1]
C0031809
Laboratory evaluation
Description

Laboratory evaluation

Data type

integer

Alias
UMLS CUI [1]
C0022885
Prior/concomitant medication
Description

Prior/concomitant medication

Data type

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013227
Pregnancy test
Description

Pregnancy test

Data type

integer

Alias
UMLS CUI [1]
C0032976
Dispense Subject Symptom Diary
Description

Dispense Subject Symptom Diary

Data type

integer

Alias
UMLS CUI [1]
C2216446
Dispense Actigraphy device
Description

Dispense Actigraphy device

Data type

integer

Alias
UMLS CUI [1]
C1171301
IRLS Rating Scale
Description

IRLS Rating Scale

Data type

integer

Alias
UMLS CUI [1]
C0681889
CGI Scales (Improvement & Severity)
Description

CGI Scales (Improvement & Severity)

Data type

integer

Alias
UMLS CUI [1]
C3639708
Insomnia Severity Index
Description

Insomnia Severity Index

Data type

integer

Alias
UMLS CUI [1]
C0917801
Written informed consent
Description

Written informed consent

Data type

integer

Alias
UMLS CUI [1]
C0021430
Dispense Patient Global Improvement Scale (PGI) Forms
Description

Dispense Patient Global Improvement Scale (PGI) Forms

Data type

integer

Alias
UMLS CUI [1,1]
C2986411
UMLS CUI [1,2]
C0349674
Patient satisfaction question
Description

Patient satisfaction question

Data type

integer

Alias
UMLS CUI [1]
C3476649
Quality of Life Questionnaire
Description

Quality of Life Questionnaire

Data type

integer

Alias
UMLS CUI [1]
C0451149
MOS Sleep Scale
Description

MOS Sleep Scale

Data type

integer

Alias
UMLS CUI [1]
C3697468
Profile of Mood States (POMS)
Description

Profile of Mood States (POMS)

Data type

integer

Alias
UMLS CUI [1]
C0451394
Hospital Anxiety and Depression Scale (HADS)
Description

Hospital Anxiety and Depression Scale (HADS)

Data type

integer

Alias
UMLS CUI [1]
C3539657
Adverse events
Description

Adverse events

Data type

integer

Alias
UMLS CUI [1]
C0877248
Subject randomization
Description

Subject randomization

Data type

integer

Alias
UMLS CUI [1]
C0034656
Pharmacogenomics sample
Description

Pharmacogenomics sample

Data type

integer

Alias
UMLS CUI [1]
C1138555
Study conclusion form
Description

Study conclusion form

Data type

integer

Alias
UMLS CUI [1]
C1707478
Back to the top of the page

Similar models

TIME AND EVENTS TABLE Ropinirole Case Report Form GSK

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
TIME AND EVENTS TABLE
Item
Assessments
integer
C0220825 (UMLS CUI [1])
Assessments
Code List
Assessments
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
IRLSSG diagnostic criteria
integer
C0035258 (UMLS CUI [1,1])
C2348561 (UMLS CUI [1,2])
Assessments
Code List
IRLSSG diagnostic criteria
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Inclusion/exclusion criteria
integer
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Assessments
Code List
Inclusion/exclusion criteria
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Subject demography
integer
C0011298 (UMLS CUI [1])
Assessments
Code List
Subject demography
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
RLS history
integer
C0035258 (UMLS CUI [1])
Assessments
Code List
RLS history
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Orthostatic blood pressure and heart rate
integer
C1095971 (UMLS CUI [1])
Assessments
Code List
Orthostatic blood pressure and heart rate
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Weight
integer
C0220825 (UMLS CUI [1])
Assessments
Code List
Weight
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Height
integer
C0005890 (UMLS CUI [1])
Assessments
Code List
Height
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
ECG
integer
C0220825 (UMLS CUI [1])
Assessments
Code List
ECG
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Medical/surgical history
integer
C0262926 (UMLS CUI [1,1])
C0455610 (UMLS CUI [1,2])
Assessments
Code List
Medical/surgical history
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Physical examination
integer
C0031809 (UMLS CUI [1])
Assessments
Code List
Physical examination
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Laboratory evaluation
integer
C0022885 (UMLS CUI [1])
Assessments
Code List
Laboratory evaluation
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Prior/concomitant medication
integer
C2347852 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Assessments
Code List
Prior/concomitant medication
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Pregnancy test
integer
C0032976 (UMLS CUI [1])
Assessments
Code List
Pregnancy test
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Dispense Subject Symptom Diary
integer
C2216446 (UMLS CUI [1])
Assessments
Code List
Dispense Subject Symptom Diary
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Dispense Actigraphy device
integer
C1171301 (UMLS CUI [1])
Assessments
Code List
Dispense Actigraphy device
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
IRLS Rating Scale
integer
C0681889 (UMLS CUI [1])
Assessments
Code List
IRLS Rating Scale
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
CGI Scales (Improvement & Severity)
integer
C3639708 (UMLS CUI [1])
Assessments
Code List
CGI Scales (Improvement & Severity)
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Insomnia Severity Index
integer
C0917801 (UMLS CUI [1])
Assessments
Code List
Insomnia Severity Index
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Written informed consent
integer
C0021430 (UMLS CUI [1])
Assessments
Code List
Written informed consent
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Dispense Patient Global Improvement Scale (PGI) Forms
integer
C2986411 (UMLS CUI [1,1])
C0349674 (UMLS CUI [1,2])
Assessments
Code List
Dispense Patient Global Improvement Scale (PGI) Forms
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Patient satisfaction question
integer
C3476649 (UMLS CUI [1])
Assessments
Code List
Patient satisfaction question
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Quality of Life Questionnaire
integer
C0451149 (UMLS CUI [1])
Assessments
Code List
Quality of Life Questionnaire
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
MOS Sleep Scale
integer
C3697468 (UMLS CUI [1])
Assessments
Code List
MOS Sleep Scale
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Profile of Mood States (POMS)
integer
C0451394 (UMLS CUI [1])
Assessments
Code List
Profile of Mood States (POMS)
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Hospital Anxiety and Depression Scale (HADS)
integer
C3539657 (UMLS CUI [1])
Assessments
Code List
Hospital Anxiety and Depression Scale (HADS)
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Adverse events
integer
C0877248 (UMLS CUI [1])
Assessments
Code List
Adverse events
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Subject randomization
integer
C0034656 (UMLS CUI [1])
Assessments
Code List
Subject randomization
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Pharmacogenomics sample
integer
C1138555 (UMLS CUI [1])
Assessments
Code List
Pharmacogenomics sample
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Item
Study conclusion form
integer
C1707478 (UMLS CUI [1])
Assessments
Code List
Study conclusion form
CL Item
Screening (1)
C1409616 (UMLS CUI-1)
(Comment:en)
CL Item
Baseline (2)
C1442488 (UMLS CUI-1)
(Comment:en)
CL Item
12 Week Double-Blind Treatment Phase (3)
C0013072 (UMLS CUI-1)
C0814495 (UMLS CUI-2)
(Comment:en)
CL Item
Early withdrawal (4)
C2349954 (UMLS CUI-1)
(Comment:en)
CL Item
Follow Up (5)
C1522577 (UMLS CUI-1)
(Comment:en)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial